Newtopia (TSXV:NEWU) is a preventative health company dedicated to disease prevention. The company’s patented precision health system translates personal genetic information via a saliva test to a weight management and 1:1 counselling program. The custom program manages Metabolic Syndrome (“Met S”), a predisposition that raises the risk of developing heart disease, diabetes, stroke and other health problems.

Following analysis of intake testing, Newtopia delivers a personalized wellbeing program with their network of Inspirators to address nutritional and activity needs to mitigate risk of developing a chronic disease.

Newtopia partnered with insurance company Aetna to complete a clinical trial using the Newtopia system. Results were published in the article entitled “Reducing Metabolic Syndrome Using a Personalized Wellness Program” in the Journal of Occupational and Environmental Medicine. The data supports both the ROI and clinical impact following use of the Newtopia preventative health strategy for individuals with identifiable chronic disease risk. The key findings included:

Sustained employee engagement of over 50% after the first year of the program

76% of participants lost an average of more than 10lbs

Clinically significant reduction in Metabolic Syndrome risk factors

Reduction of medical costs by $1,464 per participant, showing a positive ROI in the first year.

We are proud to highlight Newtopia’s intentional preventative health objective as it aligns with the United Nations Sustainable Development Goal of ‘Health & Wellbeing’ (SDG #3), specifically, allocating resources to the reduction of risk for developing non-communicable diseases causing premature death. By providing a personalized program for individuals with metabolic syndrome, Newtopia is delivering measurable social impact that addresses both cardiovascular and diabetic disease risk.